Plakous Therapeutics, Inc. — Form D
Plakous Therapeutics, Inc. of WINSTON-SALEM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-24. The offering totals $4.0M, of which $175K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-01-24
- Form: D
- Accession: 0001709440-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $175K
- Remaining: $3.8M
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2019-03-08
- Revenue range: Decline to Disclose
- SEC file number: 021-358913
Issuer
- Name: Plakous Therapeutics, Inc.
- CIK: 0001709440
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2016
- Address: 755 HIGHLAND OAKS DRIVE, WINSTON-SALEM, NC, 27103
- Phone: 336-782-3106
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Allison London Brown | Director | Winston-Salem, NC |
| Peter A Johnson | Director | San Francisco, CA |
| Seth A Tomblyn | Director | Winston-Salem, NC |
| Scott A Washburn | Director | Winston-Salem, NC |
| Robert W Boyce | Executive Officer | Winston-Salem, NC |
| Seth A Tomblyn | Executive Officer | Winston-Salem, NC |
| Scott A Washburn | Executive Officer | Winston-Salem, NC |
Other filings by this issuer (1)
More